DE122007000101I1 - Papillomavirus vakzine - Google Patents
Papillomavirus vakzineInfo
- Publication number
- DE122007000101I1 DE122007000101I1 DE122007000101C DE122007000101C DE122007000101I1 DE 122007000101 I1 DE122007000101 I1 DE 122007000101I1 DE 122007000101 C DE122007000101 C DE 122007000101C DE 122007000101 C DE122007000101 C DE 122007000101C DE 122007000101 I1 DE122007000101 I1 DE 122007000101I1
- Authority
- DE
- Germany
- Prior art keywords
- papilloma virus
- virus vaccine
- antibodies
- useful
- mimics
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229960002566 papillomavirus vaccine Drugs 0.000 title 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 2
- 101710121996 Hexon protein p72 Proteins 0.000 abstract 1
- 101710125418 Major capsid protein Proteins 0.000 abstract 1
- 208000009608 Papillomavirus Infections Diseases 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 208000003154 papilloma Diseases 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
- 210000002845 virion Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90310992A | 1992-06-25 | 1992-06-25 | |
PCT/US1993/006109 WO1994000152A1 (en) | 1992-06-25 | 1993-06-24 | Papillomavirus vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
DE122007000101I1 true DE122007000101I1 (de) | 2008-03-27 |
Family
ID=25416951
Family Applications (9)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE122007000095C Pending DE122007000095I1 (de) | 1992-06-25 | 1993-06-24 | Papillomavirus vakzine |
DE122007000099C Pending DE122007000099I1 (de) | 1992-06-25 | 1993-06-24 | Papillomavirus vakzine |
DE69334192T Expired - Lifetime DE69334192T2 (de) | 1992-06-25 | 1993-06-24 | Papillomavirus vakzine |
DE122007000098C Pending DE122007000098I1 (de) | 1992-06-25 | 1993-06-24 | Papillomavirus vakzine |
DE122007000097C Pending DE122007000097I1 (de) | 1992-06-25 | 1993-06-24 | Papillomavirus vakzine |
DE122007000096C Pending DE122007000096I1 (de) | 1992-06-25 | 1993-06-24 | Papillomavirus vakzine |
DE122007000094C Pending DE122007000094I1 (de) | 1992-06-25 | 1993-06-24 | Papillomavirus vakzine |
DE122007000101C Pending DE122007000101I1 (de) | 1992-06-25 | 1993-06-24 | Papillomavirus vakzine |
DE122007000100C Pending DE122007000100I1 (de) | 1992-06-25 | 1993-06-24 | Papillomavirus vakzine |
Family Applications Before (7)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE122007000095C Pending DE122007000095I1 (de) | 1992-06-25 | 1993-06-24 | Papillomavirus vakzine |
DE122007000099C Pending DE122007000099I1 (de) | 1992-06-25 | 1993-06-24 | Papillomavirus vakzine |
DE69334192T Expired - Lifetime DE69334192T2 (de) | 1992-06-25 | 1993-06-24 | Papillomavirus vakzine |
DE122007000098C Pending DE122007000098I1 (de) | 1992-06-25 | 1993-06-24 | Papillomavirus vakzine |
DE122007000097C Pending DE122007000097I1 (de) | 1992-06-25 | 1993-06-24 | Papillomavirus vakzine |
DE122007000096C Pending DE122007000096I1 (de) | 1992-06-25 | 1993-06-24 | Papillomavirus vakzine |
DE122007000094C Pending DE122007000094I1 (de) | 1992-06-25 | 1993-06-24 | Papillomavirus vakzine |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE122007000100C Pending DE122007000100I1 (de) | 1992-06-25 | 1993-06-24 | Papillomavirus vakzine |
Country Status (12)
Country | Link |
---|---|
US (2) | US20020068326A1 (de) |
EP (2) | EP1835029A1 (de) |
AT (1) | ATE380871T1 (de) |
AU (1) | AU697743C (de) |
DE (9) | DE122007000095I1 (de) |
DK (1) | DK0647140T3 (de) |
ES (1) | ES2294778T3 (de) |
FR (1) | FR07C0073I2 (de) |
LU (8) | LU91395I2 (de) |
NL (8) | NL300316I1 (de) |
PT (1) | PT647140E (de) |
WO (1) | WO1994000152A1 (de) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE122007000018I1 (de) | 1991-07-19 | 2007-05-24 | Univ Queensland | Polynukleotidabschnitt des HPV16-Genoms |
US5437951A (en) * | 1992-09-03 | 1995-08-01 | The United States Of America As Represented By The Department Of Health And Human Services | Self-assembling recombinant papillomavirus capsid proteins |
US8062642B1 (en) | 1993-03-09 | 2011-11-22 | University Of Rochester | Production of papillomavirus capsid protein and virus-like particles |
US6153201A (en) * | 1993-03-09 | 2000-11-28 | University Of Rochester | Oral immunization with papillomavirus virus-like particles |
DE4415743C2 (de) * | 1994-05-04 | 1996-10-10 | Deutsches Krebsforsch | Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen |
US5888516A (en) * | 1994-05-16 | 1999-03-30 | Merck & Co. Inc. | Recombinant papillomavirus vaccines |
CA2189882C (en) * | 1994-05-16 | 2005-09-20 | Kathrin U. Jansen | Papillomavirus vaccines |
AU683564B2 (en) * | 1994-05-17 | 1997-11-13 | University Of Queensland, The | Recombinant papilloma virus L1 |
AUPM566794A0 (en) * | 1994-05-17 | 1994-06-09 | University Of Queensland, The | Process and product |
JPH10506014A (ja) * | 1994-09-22 | 1998-06-16 | メルク エンド カンパニー インコーポレーテッド | ヒトパピローマウイルス6a型をコードするDNA |
AU4270196A (en) | 1994-10-07 | 1996-05-02 | Lutz Gissmann | Papilloma virus-like particles, fusion proteins and process for producing the same |
US5820870A (en) * | 1995-03-22 | 1998-10-13 | Merck & Co., Inc. | Recombinant human papillomavirus type 18 vaccine |
US5840306A (en) * | 1995-03-22 | 1998-11-24 | Merck & Co., Inc. | DNA encoding human papillomavirus type 18 |
IL117459A (en) * | 1995-03-22 | 2005-11-20 | Merck & Co Inc | Dna encoding human papillomavirus type 18 |
US6908615B1 (en) | 1996-03-18 | 2005-06-21 | Merck & Co., Inc. | DNA encoding human papilloma virus type 18 |
GB9621091D0 (en) | 1996-10-09 | 1996-11-27 | Fondation Pour Le Perfectionem | Attenuated microorganisms strains and their uses |
JP2002510976A (ja) * | 1997-07-03 | 2002-04-09 | ユニバーシティ・オブ・コロラド・ユニバーシティ・テクノロジー・コーポレイション | 均質のヒト・パピローマウイルスのカプソメアを含有する組成物、その製造方法、およびその診断的、予防的、治療的使用 |
US6228368B1 (en) | 1997-10-06 | 2001-05-08 | Loyola University Of Chicago | Papilloma virus capsomere formulations and method of use |
CA2229955C (en) | 1998-02-20 | 2003-12-09 | Medigene Gmbh | Papilloma virus capsomere vaccine formulations and methods of use |
US20020039584A1 (en) | 1998-02-20 | 2002-04-04 | Medigene Ag | Papilloma virus capsomere vaccine formulations and methods of use |
US7494658B2 (en) | 1998-02-20 | 2009-02-24 | Medigene Ag | Papilloma virus truncated L1 protein and fusion protein constructs |
US7182947B2 (en) | 1998-02-20 | 2007-02-27 | Medigene Ag | Papillomavirus truncated L1 protein and fusion protein constructs |
US6926897B1 (en) | 1998-03-24 | 2005-08-09 | Medigene Aktiengesellschaft | Medicament for the avoidance or treatment of papillomavirus-specific tumour |
EP1104442A1 (de) | 1998-07-13 | 2001-06-06 | Loyola University Of Chicago | Papillomavirus zell-rezeptor |
US6692752B1 (en) | 1999-09-08 | 2004-02-17 | Smithkline Beecham Biologicals S.A. | Methods of treating human females susceptible to HSV infection |
TR200101055T2 (tr) * | 1998-10-16 | 2001-09-21 | Smithkline Beecham Biologicals S.A. | Adjuvan sistemler ve aşılar |
GB0109297D0 (en) | 2001-04-12 | 2001-05-30 | Glaxosmithkline Biolog Sa | Vaccine |
EP1425423B1 (de) | 2001-08-13 | 2010-06-23 | University of Rochester | Transkutane immunisierung gegen papillomavirus mit virusähnlichen papillomaviruspartikeln |
GB0206360D0 (en) * | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
CA2531773A1 (en) | 2003-07-21 | 2005-02-17 | Transgene S.A. | Novel multifunctional cytokines |
TWI457133B (zh) | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | 新穎組合物 |
EP2068918B1 (de) | 2006-09-26 | 2012-05-02 | Infectious Disease Research Institute | Impfstoffzusammensetzung mit einem synthetischen adjuvans |
US20090181078A1 (en) | 2006-09-26 | 2009-07-16 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
EA021391B1 (ru) | 2007-03-02 | 2015-06-30 | Глаксосмитклайн Байолоджикалс С.А. | Способ индукции иммунного ответа, вакцинная композиция, ее применение и набор |
CN102099053A (zh) | 2008-05-26 | 2011-06-15 | 卡迪拉保健有限公司 | 麻疹-人乳头瘤组合疫苗 |
GB0815872D0 (en) | 2008-09-01 | 2008-10-08 | Pasteur Institut | Novel method and compositions |
GB0820822D0 (en) | 2008-11-13 | 2008-12-24 | Inst Catala D Oncologia | Novel product and processes |
WO2010112533A1 (en) * | 2009-04-03 | 2010-10-07 | Deutsches Krebsforschungszentrum | Enhanced production of papillomavirus-like particles with a modified baculovirus expression system |
EP2437753B1 (de) | 2009-06-05 | 2016-08-31 | Infectious Disease Research Institute | Synthetische glucopyranosyl-lipid-adjuvanzien und impfstoffzusammensetzungen die diese enthalten |
WO2011026111A1 (en) | 2009-08-31 | 2011-03-03 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Oral delivery of a vaccine to the large intestine to induce mucosal immunity |
CA2795403C (en) | 2010-04-08 | 2019-01-15 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | B-cell antigen presenting cell assay |
US9044420B2 (en) | 2011-04-08 | 2015-06-02 | Immune Design Corp. | Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses |
US11510875B2 (en) | 2012-02-07 | 2022-11-29 | Access To Advanced Health Institute | Adjuvant formulations comprising TLR4 agonists and methods of using the same |
EP3388835B1 (de) | 2012-05-16 | 2020-04-01 | Immune Design Corp. | Impfstoffe gegen hsv-2 |
JP6430949B2 (ja) | 2012-10-23 | 2018-11-28 | エモリー ユニバーシティ | Gm−csfとil−4のコンジュゲート、組成物、ならびにそれに関連する方法 |
US8957047B2 (en) | 2013-04-18 | 2015-02-17 | Immune Design Corp. | GLA monotherapy for use in cancer treatment |
US9463198B2 (en) | 2013-06-04 | 2016-10-11 | Infectious Disease Research Institute | Compositions and methods for reducing or preventing metastasis |
AU2014373928C1 (en) | 2013-12-31 | 2020-12-17 | Access To Advanced Health Institute | Single vial vaccine formulations |
EP3420355A1 (de) | 2016-02-22 | 2019-01-02 | Boehringer Ingelheim Vetmedica GmbH | Verfahren zur immobilisierung von biomolekülen |
MX2018013640A (es) | 2016-05-16 | 2019-08-01 | Infectious Disease Res Inst | Liposomas pegiladas y metodos de uso. |
HUE059605T2 (hu) | 2016-05-16 | 2022-11-28 | Access To Advanced Health Inst | TLR agonista tartalmú készítmény és használati eljárások |
US11173126B2 (en) | 2016-06-01 | 2021-11-16 | Infectious Disease Research Institute | Nanoalum particles comprising a PAA sizing agent |
EP3638207A1 (de) | 2017-06-15 | 2020-04-22 | Infectious Disease Research Institute | Nanostrukturierte lipidträger sowie stabile emulsionen und ihre verwendung |
AU2018330165A1 (en) | 2017-09-08 | 2020-04-02 | Access To Advanced Health Institute | Liposomal formulations comprising saponin and methods of use |
KR20220125149A (ko) | 2019-05-25 | 2022-09-14 | 액세스 투 어드밴스드 헬스 인스티튜트 | 애주번트 백신 에멀션을 분무 건조시키기 위한 조성물 및 방법 |
AU2021337493A1 (en) | 2020-09-04 | 2023-05-18 | Access To Advanced Health Institute | Co-lyophilized rna and nanostructured lipid carrier |
WO2024052882A1 (en) | 2022-09-09 | 2024-03-14 | Access To Advanced Health Institute | Immunogenic vaccine composition incorporating a saponin |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57106626A (en) * | 1980-12-22 | 1982-07-02 | Teijin Ltd | Cytotoxic protein complex and its preparation |
US4455296A (en) * | 1982-02-02 | 1984-06-19 | Board Of Regents, The University Of Texas System | Hybrid cell lines producing monoclonal antibodies directed against Haemophilus influenzae |
US4671958A (en) * | 1982-03-09 | 1987-06-09 | Cytogen Corporation | Antibody conjugates for the delivery of compounds to target sites |
FR2524487B1 (fr) * | 1982-04-05 | 1985-11-22 | Pasteur Institut | Fragments d'adn codant pour des polypeptides contenant au moins un determinant antigenique des papillomavirus, notamment du type hpv 1a et polypeptides correspondants |
US4596674A (en) * | 1984-09-11 | 1986-06-24 | Merck & Co., Inc. | Immunogenic HAV peptides |
DE3625257A1 (de) * | 1986-07-23 | 1988-02-04 | Behringwerke Ag | Expressionsprodukte der menschlichen papillomviren typ 16 und 18, fuer diese proteine spezifische antikoerper und diese antikoerper bzw. entsprechende dna enthaltende diagnostika |
NZ223009A (en) * | 1986-12-31 | 1990-06-26 | Nl Rivm Of Thoven | Oligosaccharides containing d-ribose d-ribitol and phosphate units mimicing haemophilus influenzae type b antigens |
EP0320942A3 (de) * | 1987-12-18 | 1989-10-04 | American Cyanamid Company | Polysaccharide und makromolekulare Verbindungen davon |
KR910016343A (ko) * | 1990-03-20 | 1991-11-05 | 스타인, 부그 | 사람 파필로마바이러스(hpv) 16 단백질의 혈청반응성 에피토프 |
DE122007000018I1 (de) | 1991-07-19 | 2007-05-24 | Univ Queensland | Polynukleotidabschnitt des HPV16-Genoms |
-
1993
- 1993-06-24 WO PCT/US1993/006109 patent/WO1994000152A1/en active IP Right Grant
- 1993-06-24 DE DE122007000095C patent/DE122007000095I1/de active Pending
- 1993-06-24 AT AT93916789T patent/ATE380871T1/de active
- 1993-06-24 DE DE122007000099C patent/DE122007000099I1/de active Pending
- 1993-06-24 DE DE69334192T patent/DE69334192T2/de not_active Expired - Lifetime
- 1993-06-24 DE DE122007000098C patent/DE122007000098I1/de active Pending
- 1993-06-24 DK DK93916789T patent/DK0647140T3/da active
- 1993-06-24 DE DE122007000097C patent/DE122007000097I1/de active Pending
- 1993-06-24 ES ES93916789T patent/ES2294778T3/es not_active Expired - Lifetime
- 1993-06-24 PT PT93916789T patent/PT647140E/pt unknown
- 1993-06-24 DE DE122007000096C patent/DE122007000096I1/de active Pending
- 1993-06-24 EP EP07013259A patent/EP1835029A1/de not_active Withdrawn
- 1993-06-24 DE DE122007000094C patent/DE122007000094I1/de active Pending
- 1993-06-24 DE DE122007000101C patent/DE122007000101I1/de active Pending
- 1993-06-24 DE DE122007000100C patent/DE122007000100I1/de active Pending
- 1993-06-24 EP EP93916789A patent/EP0647140B1/de not_active Expired - Lifetime
-
1995
- 1995-01-24 AU AU11352/95A patent/AU697743C/en not_active Expired
- 1995-06-07 US US08/473,228 patent/US20020068326A1/en not_active Abandoned
-
1996
- 1996-12-16 US US08/764,926 patent/US8012679B1/en not_active Expired - Fee Related
-
2005
- 2005-12-14 LU LU91395C patent/LU91395I2/fr unknown
-
2007
- 2007-12-14 LU LU91397C patent/LU91397I2/fr unknown
- 2007-12-14 LU LU91394C patent/LU91394I2/fr unknown
- 2007-12-14 NL NL300316C patent/NL300316I1/nl unknown
- 2007-12-14 NL NL300321C patent/NL300321I1/nl unknown
- 2007-12-14 LU LU91393C patent/LU91393I2/fr unknown
- 2007-12-14 LU LU91400C patent/LU91400I2/fr unknown
- 2007-12-14 LU LU91396C patent/LU91396I2/fr unknown
- 2007-12-14 NL NL300322C patent/NL300322I1/nl unknown
- 2007-12-14 NL NL300315C patent/NL300315I2/nl unknown
- 2007-12-14 NL NL300317C patent/NL300317I1/nl unknown
- 2007-12-14 NL NL300319C patent/NL300319I1/nl unknown
- 2007-12-14 NL NL300320C patent/NL300320I1/nl unknown
- 2007-12-14 NL NL300318C patent/NL300318I2/nl unknown
- 2007-12-14 LU LU91399C patent/LU91399I2/fr unknown
- 2007-12-14 LU LU91398C patent/LU91398I2/fr unknown
- 2007-12-21 FR FR07C0073C patent/FR07C0073I2/fr active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69334192D1 (de) | Papillomavirus vakzine | |
DE122008000010I1 (de) | Sich selbst-zusammenbauende rekombinante hpv16 papillomavirus-hüllproteine | |
Schlegel et al. | Protecting against canine oral papillomavirus |